Hidradenitis suppurativa and metabolic syndrome: a comparative cross‐sectional study of 3207 patients
- 11 June 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 173 (2), 464-470
- https://doi.org/10.1111/bjd.13777
Abstract
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease.To evaluate the association between HS and metabolic syndrome and its component morbidities in a large, community-based cohort of patients with HS, using the database of Clalit Health Services, the largest public healthcare provider in Israel.A cross-sectional study was performed. Metabolic syndrome was defined as the presence of at least three of the following conditions: diabetes, hyperlipidaemia, hypertension and obesity. The association between HS and metabolic syndrome was assessed by a multivariate logistic regression model, adjusting for age, sex, diabetes, hypertension, hyperlipidaemia, obesity and smoking status.The study included 3207 patients with HS (general frequency of 0·07%) diagnosed by a dermatologist in primary-care centres, and 6412 age- and sex-matched control patients without HS. HS was significantly associated with metabolic syndrome [odds ratio (OR) 1·61, 95% confidence interval (CI) 1·36-1·89], diabetes (OR 1·41, 95% CI 1·19-1·66), obesity (OR 1·71, 95% CI 1·53-1·91), hyperlipidaemia (OR 1·14, 95% CI 1·02-1·28) and hypertension (OR 1·19, 95% CI 1·03-1·38).We found an association between HS and diabetes, hyperlipidaemia, obesity, hypertension and metabolic syndrome among a large community-based cohort of patients with HS. Clinicians should take into account that patients with HS may have one or more undiagnosed components of metabolic syndrome despite their young age. Thus, appropriate targeted screening is advised.Keywords
This publication has 38 references indexed in Scilit:
- Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United StatesJournal of the American Academy of Dermatology, 2013
- TNF- antagonists beyond approved indications: stories of success and prospects for the futureQJM: An International Journal of Medicine, 2010
- Painful Hidradenitis SuppurativaThe Clinical Journal of Pain, 2010
- Psychophysical Aspects of Hidradenitis SuppurativaActa Dermato Venereologica, 2010
- Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trialJournal of the American Academy of Dermatology, 2010
- Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesityBritish Journal of Dermatology, 2009
- Hidradenitis suppurativa: A comprehensive reviewJournal of the American Academy of Dermatology, 2009
- Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studiesJournal of the American Academy of Dermatology, 2008
- The prevalence of hidradenitis suppurativa and its potential precursor lesionsJournal of the American Academy of Dermatology, 1996
- Recurrence after surgical treatment of hidradenitis suppurativa.BMJ, 1987